EDGAR Filing Documents for 0001140361-22-002388

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001140361-22-002388

Filing Date

2022-01-21

Accepted

2022-01-21 16:10:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ny20002147x1_s3.htm	S-3	440249
2	EXHIBIT 5.1	ny20002147x1_ex5-1.htm	EX-5.1	5279
3	EXHIBIT 23.2	ny20002147x1_ex23-2.htm	EX-23.2	2155
4	EXHIBIT 23.3	ny20002147x1_ex23-3.htm	EX-23.3	1956
5		logo_firstwave.jpg	GRAPHIC	117810
	Complete submission text file	0001140361-22-002388.txt		612875

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-262276 | Film No.: 22546047
SIC: 2834 Pharmaceutical Preparations